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AbstrAct
Colorectal cancer (CRC) cancer screening uptake is low 
in our diverse, outpatient teaching clinic. A state-level 
public screening programme was recently launched 
that provides faecal immunochemical tests or screening 
colonoscopy to all citizens aged 50–69 years via mailed 
invitations, with the possibility of earlier, opportunistic 
inclusion. Mailed outreach is expected to be rolled out 
over the next 5 years. In the interim, we aimed to increase 
CRC screening by accelerating the inclusion of patients 
into the programme by implementing a provider feedback 
programme with residents. We used billing reports to 
define the eligible target population and monthly lists of 
included patients to track progress. All residents received 
a standard intervention that provided basic training and 
communication tools facilitating shared decision making 
in CRC screening decisions. We then developed and 
implemented the intervention over 3 Plan-Do-Study-Act 
cycles in 2 of 4 groups of residents, each with 7 residents 
and approximately 250 eligible patients. The intervention 
consisted of individualised reports on the proportion of 
each resident’s patients that had been included in the 
screening programme and the names of patients who 
had not yet been included. The first group that received 
the intervention had included 58 of 232 eligible patients 
(25%) at 8 months after the feedback intervention and 
the second group 51 of 249 eligible patients (20%) at 
4 months. In comparison, the 2 groups with only the 
standard intervention had included 32 of 252 (13%) 
and 27 of 260 (10%) of their patients, respectively, at 
11 months after the baseline intervention. These results 
suggest that provider feedback to medical residents 
can promote resident self-awareness and increase the 
proportion of patients included in a public programme 
when provided in addition to educational interventions.
Problem
Recent data suggested that only 33% of 
eligible patients were up to date with 
colorectal cancer (CRC) screening at our 
academic primary care practice.1 A new 
cantonal screening programme will not be 
fully functional until 2022. Given our low 
screening participation currently and lag 
time for mailed screening outreach from the 
screening program to take effect, we aimed to 
increase screening by focusing on measures 
not included in the organised programme 
that might help medical residents to improve 
screening uptake by their patients.
background
CRC is the second leading cause of cancer 
mortality in Switzerland. Screening 
programmes for CRC can reduce CRC 
mortality and have shown a good cost-ben-
efit ratio, as early detection can improve 
survival.2 3 The most recently available data 
for our outpatient clinic in Lausanne, Swit-
zerland, show that around 33% of patients 
are up to date with CRC screening.1 4 A 
systematic CRC screening programme was 
initiated in our canton that offers the choice 
between two fully reimbursed screening 
tests: the faecal immunochemical test (FIT) 
or screening colonoscopy.5 The Department 
of Ambulatory Care and Community Medi-
cine at the Lausanne University developed 
a pilot project to implement the screening 
programme all over the canton of Vaud. The 
CRC screening programme started in 2015, 
with our department identified as a pilot unit 
to test the e-platform, the patient information 
delivery process and entry of patients into the 
programme.6 The programme has a target 
screening population of 170 000 people 
who will be mailed invitation letters to assist 
with a specific medical counselling visit with 
their general practitioner about bowel cancer 
screening. The main goals of this project 
were to design, implement and evaluate 
measures to increase the uptake of the bowel 
cancer screening programme in an academic 
outpatient primary care practice. We aimed 
to answer two questions: How can we increase 
CRC screening uptake? Which screening test 
(FIT or colonoscopy) is used more often? The 
success of different measures implemented 
will be measured by the increase of patients 
included in the cantonal programme, a proxy 
for increased screening uptake.
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measuremenT
Our main outcome measure was the proportion of 
eligible patients enrolled in the cancer screening e-plat-
form by each group of residents. The medical residents in 
our outpatient clinic are separated into four groups, each 
supervised by an attending physician. Our clinic’s elec-
tronic health record does not allow for easy identification 
of patients eligible for screening or the tracking of quality 
metrics such as screening uptake. We therefore relied on 
the number of inclusions in the cantonal programme 
by physicians via the programme e-platform as a proxy 
for increased screening uptake. We did not verify actual 
screening completion. On inclusion in the programme, 
patients could be included for screening with FIT or colo-
noscopy, for temporary exclusion (already up to date with 
screening or short-term illness), or permanent exclusion 
(identified as high-risk and not screening eligible or other 
definitive exclusion criteria). We checked the number 
of inclusions to the platform at the end of each month, 
stratified by group to compare intervention groups with 
control groups before and after the intervention imple-
mentation. We used billing reports from August 2014 to 
August 2015 to identify patients who had attended at least 
one primary care visit and were born in the years eligible 
for inclusion (ages 50–69 years). We expected the total 
number of eligible patients seen by each group of resi-
dents to be stable during the duration of the study.
statistical analyses
Our primary outcome was the cumulative proportion of 
eligible patients from each group of residents enrolled in 
the cantonal programme. This proportion was compared 
between intervention and control groups at 8 months 
after intervening in the first intervention group (red), and 
4 months after intervening in the second group (orange). 
We also tracked the number of inclusions per month and 
the proportion of patients included for each test type (FIT 
vs colonoscopy) and with a temporary exclusion from the 
programme (most often those already up to date with 
screening). We started to monitor the e-platform uptakes 
for each group just after delivering presenting informa-
tion about the programme to all residents.
design
This was a non-randomised intervention with two inter-
vention and two parallel control groups of residents using 
sequential Plan-Do-Study-Act (PDSA) cycles. Our project 
ran from September 2015 to August 2016. We focused on 
four groups of medical residents (Red, Orange, Green 
and Blue) each with seven medical residents in general 
internal medicine and around 250 patients in the target 
age population for CRC cancer screening. These groups 
are used for the supervision of residents and meet weekly 
for teaching and problem solving.
baseline intervention in all groups
Our baseline intervention for all residents was to inform 
them about the new cantonal screening programme via 
the weekly morning report for all residents and weekly 
conferences with attending physicians. We also gave tuto-
rials and access to the electronic platform for including 
new patients in the screening programme and placed 
patient-information sheets in every consultation room. 
All materials were available to residents on our outpatient 
clinic website.
intervention groups
We implemented and tested a multidimensional, data-
driven, sequential quality improvement intervention 
based on the PDSA method. We intervened in two groups 
of residents (Red and Orange), while the other two 
groups served as controls (Blue and Green).
sTraTegy
We used three improvement PDSA cycles and we collected 
our outcomes data continuously throughout to test the 
results of each improvement cycle.
Pdsa cycle 1
Our first cycle was based on the intervention delivered 
in all groups in September 2015, which was to provide 
all residents with information about the programme, 
patient materials and access to the on-line platform. We 
then measured uptake and saw that it was low, at <5% in 
all groups. We asked residents in the Red group about 
possible interventions and the feasibility of interventions 
in their practice. From all medical residents’ proposals, 
we chose a single action that could fit in our setting and 
that was not time-consuming or that needed funding. We 
also showed results from the baseline intervention and 
discussed possible interventions with senior leadership 
for the clinic to get their support and buy-in.
Pdsa cycle 2
For the second PDSA cycle, beginning in December 2015 
we gave a report to each medical resident at the end of 
each month that listed their patients eligible for screening 
and the proportion that had been included in the canton 
programme. Our assumption was that increasing aware-
ness about the proportion of patients screened by each 
resident would motivate them to take necessary organi-
sational steps and change their prescription behaviour 
in order to impact their future performance. We were 
careful to keep information private and residents weren’t 
given a comparison with their peers. We also gave reports 
to attending physicians for their patients. We gave the 
reports in person during weekly meetings with all avail-
able residents and supervising physicians, when they also 
had an opportunity to discuss the reports with their peers. 
We did not compare between residents the proportion of 
patients already included in the programme or say what 
proportion would be desirable.
Feedback after the second round was generally posi-
tive, both in terms of the proportion of patients included 
in the programme (which increased sharply in the red 
group) and feedback from residents. Some residents felt 
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ashamed at their low proportion of patients included, but 
said that it motivated them. Residents felt that discrep-
ancies between the reports and their current panel of 
patients were minor, despite the lists being generated 
from patients seen the year prior.
Pdsa cycle 3
After the success of the individual reports in the Red 
group, we wanted to see if the same intervention could 
work in a second group that had not participated in 
the development of the intervention. Given the positive 
feedback from the Red group, we made no changes and 
delivered screening uptake reports to each resident in 
the orange group. We gave the individual uptakes ratio 
reports in May and June 2016, and we did a follow-up of 
the daily uptakes at the e-platform the following weeks. 
The uptake reports were again well received.
resulTs
The expected eligible population (patients aged 50–69 
years seen for primary care the year prior) for the 
screening programme was 993 patients, divided in almost 
equal numbers between the four groups: Red 232, Green 
252, Orange 249 and Blue 260. A total of 168 patients was 
included in the screening programme during the study 
period (17% of those eligible). The difference between 
the groups where the intervention was implemented and 
the other two was significant and temporally related with 
interventions in those groups (figure 1).
Uptake in the first intervention group (Red) increased 
from 5 to 20 inclusions from December to the end of 
January. This means that the proportion of eligible 
patients included from the Red group increased from 
2.2% to 8.6% in the month following the intervention. 
At the end of April, 4 months later and after two indi-
vidual uptake report rounds (end of December 2015 and 
January 2016), the Red group had included a total of 44 
patients (19% included). After 8 months of follow-up, 
and 6 months after the intervention, 58 patients had been 
included (25% included).
We began two rounds of individual report transmission 
to medical resident in the Orange group in May 2016, 
labelled as PDSA 3 (figure 1). We had an 88% increase in 
inclusions for the Orange group after the first round. The 
number of inclusions increased from 17 (7% of those 
eligible) to 32 (17% included) 1 month later (figure 2).
As a comparison, we measured the number of inclu-
sions in the two control groups (Blue and Green), where 
the intervention of giving feedback about individual 
uptake proportions was not implemented. After 1 year of 
follow-up, the Blue group screening uptake ratio was 13% 
and the Green group was 10% (figure 2). When using 
Figure 1 Cumulative proportion of eligible patients included in the cantonal programme. PDSA cycles 1 and 2 were with the 
Red group, PDSA cycle 3 with the Orange group. PDSA, Plan-Do-Study-Act .
4 Mota P, et al. BMJ Open Quality 2019;8:e000452. doi:10.1136/bmjoq-2018-000452
Open access 
a χ2 test to compare intervention with control groups, 
109 of 481 were included in intervention, and 59 of 512 
included in control groups, p<0.001.
Taking into account the uptake types, 46 patients were 
included for FIT and 73 for colonoscopies. There were 
59 patients in the 50–69 years age range included in the 
programme as ‘not eligible’, 18 with a definitive exclusion 
criteria (high risk of CRC) and 31 with a temporary exclu-
sion (colonoscopy in the last 5 years, concomitant disease 
or refusal).
lessons and limitations
We learnt two primary lessons from this project: how 
to track a quality indicator for routine prevention 
in our clinic and that individual performance feed-
back increased the number of inclusions in our local 
screening programme. The use of billing reports to 
generate patient lists for each resident and the number 
of patients included in the canton programme provided 
a performance indicator that could be easily updated 
monthly. We wondered which intervention in the liter-
ature would be suitable in a Swiss-European university 
hospital context. Publicly ranking the performance 
physicians, as has been reported internationally,7 is 
likely to be seen as too competitive in Switzerland, 
particularly between physicians in training. We tested 
individual anonymised performance reports and not 
public lists of best performers for this reason. Physi-
cian reminders in other settings have only resulted 
in 2%–5% increases in CRC screening completion,8 9 
though a meta-analysis showed a 13% increase when 
looking at all preventive services.10 We observed an 11% 
increase in the proportion of eligible patients included 
in the programme. The intervention was well accepted 
by the medical residents. It would appear that there is a 
place for this type of intervention in our Swiss academic 
environment.
Limitations to our approach were that it required 
manual creation of performance reports and that our 
outcome variable measured physician inclusion using 
the e-platform and not actual screening participation. 
As our electronic health record does not allow for the 
generation of lists of patients needing preventive services, 
we were obliged to manually generate the performance 
reports. While this worked when we had a motivated 
resident participating in the project, it will be difficult 
to sustain going forward. Future projects could verify 
that the majority of patients included in the programme 
remain up to date with screening.
Figure 2 Number of patients included each month between September 2015 and August 2016, stratified by group of 
residents. Timing of PDSA cycles marked with red arrows. Interventions were in the Red (PDSA cycles 1 and 2) and Orange 
(PDSA cycle 3) groups. PDSA, Plan-Do-Study-Act .
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conclusion
Our intervention of giving individual provider feedback 
to medical residents about their screening uptake resulted 
in 23% of eligible patients being included, as opposed to 
12% in control groups, p<0.001. We conclude that giving 
feedback as individual uptake reports to medical resi-
dents can be a good tool of self-awareness and can help 
to increase the cancer screening programme uptakes. 
Future projects could include developing automated, 
computer-generated performance reports and tracking 
actual screening completion.
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